Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,917 | 121,322 | 41,870 | 33,334 | 46,802 |
| Marketable Securities | 267,962 | 262,222 | 273,305 | 316,400 | 331,133 |
| Receivables | 1,048 | 858 | 1,826 | 1,538 | 2,833 |
| TOTAL | $319,388 | $394,375 | $331,540 | $364,174 | $392,182 |
| Non-Current Assets | |||||
| PPE Net | 87,534 | 92,116 | 96,836 | 101,707 | 106,331 |
| Investments And Advances | 47,162 | 7,595 | 980 | 0 | 7,291 |
| Other Non-Current Assets | 74,733 | 75,806 | 76,861 | 77,907 | 78,953 |
| TOTAL | $209,429 | $175,517 | $174,677 | $179,614 | $192,575 |
| Total Assets | $528,817 | $569,892 | $506,217 | $543,788 | $584,757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,495 | 6,765 | 4,719 | 5,706 | 7,506 |
| Accrued Expenses | 22,654 | 32,043 | 27,514 | 28,540 | 29,469 |
| TOTAL | $34,793 | $45,369 | $39,094 | $41,333 | $44,690 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 159 | 685 | 1,110 | 1,929 |
| Other Non-Current Liabilities | 97,042 | 98,408 | 98,706 | 99,678 | 102,312 |
| TOTAL | $97,042 | $98,408 | $98,706 | $99,678 | $102,312 |
| Total Liabilities | $131,835 | $143,777 | $137,800 | $141,011 | $147,002 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,878 | 113,832 | 99,238 | 98,602 | 98,562 |
| Common Shares | 114 | 114 | 99 | 99 | 99 |
| Retained earnings | -1,298,163 | -1,259,736 | -1,211,732 | -1,167,610 | -1,122,440 |
| Other shareholders' equity | -419 | -191 | 18 | -496 | -584 |
| TOTAL | $396,982 | $426,115 | $368,417 | $402,777 | $437,755 |
| Total Liabilities And Equity | $528,817 | $569,892 | $506,217 | $543,788 | $584,757 |